Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Glomerulonephritis in Adults

被引:27
|
作者
Cybulsky, Andrey V. [1 ]
Walsh, Michael [2 ]
Knoll, Greg [3 ]
Hladunewich, Michelle [4 ]
Bargman, Joanne [4 ]
Reich, Heather [4 ]
Humar, Atul [5 ]
Samuel, Susan [6 ]
Bitzan, Martin [7 ]
Zappitelli, Michael [7 ]
Dart, Allison [8 ]
Mammen, Cherry [9 ]
Pinsk, Maury [6 ]
Muirhead, Norman [10 ]
机构
[1] McGill Univ, Dept Med, Montreal, PQ, Canada
[2] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada
[3] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Univ Alberta, Edmonton, AB, Canada
[6] Univ Alberta, Dept Pediat, Edmonton, AB, Canada
[7] Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada
[8] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada
[9] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada
[10] Univ Western Ontario, Dept Med, Div Nephrol, London, ON N6A 5A5, Canada
关键词
Clinical practice guideline implementation; KDIGO (Kidney Disease: Improving Global Outcomes); Canadian Society of Nephrology (CSN); nephrotic syndrome; glomerulonephritis; ANTIBODY-ASSOCIATED VASCULITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TERM-FOLLOW-UP; IDIOPATHIC MEMBRANOUS NEPHROPATHY; CHRONIC KIDNEY-DISEASE; DENSE DEPOSIT DISEASE; IGA NEPHROPATHY; LONG-TERM; MYCOPHENOLATE-MOFETIL; OXFORD CLASSIFICATION;
D O I
10.1053/j.ajkd.2013.12.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for management of glomerulonephritis was recently released. The Canadian Society of Nephrology convened a working group to review the recommendations and comment on their relevancy and applicability to the Canadian context. A subgroup of adult nephrologists reviewed the guideline statements for management of glomerular disease in adults and agreed with most of the guideline statements developed by KDIGO. This commentary highlights areas for which there is lack of evidence and areas in need of translation of evidence into clinical practice. Areas of controversy or uncertainty, including the choice of second-line agents, are discussed in more detail. Existing practice variation also is addressed. The relevance of treatment recommendations to the Canadian practitioner is discussed. (C) 2014 by the National Kidney Foundation, Inc.
引用
收藏
页码:363 / 377
页数:15
相关论文
共 50 条
  • [41] Vascular Access for Intensive Maintenance Hemodialysis: A Systematic Review for a Canadian Society of Nephrology Clinical Practice Guideline
    Mustafa, Reem A.
    Zimmerman, Deborah
    Rioux, Jean-Philippe
    Suri, Rita S.
    Gangji, Azim
    Steele, Andrew
    MacRae, Jennifer
    Pauly, Robert P.
    Perkins, David N.
    Chan, Christopher T.
    Copland, Michael
    Komenda, Paul
    McFarlane, Philip A.
    Lindsay, Robert
    Pierratos, Andreas
    Nesrallah, Gihad E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (01) : 112 - 131
  • [42] ADHERENCE WITH THE 2012 KDIGO GUIDELINE FOR THE EVALUATION AND MANAGEMENT OF CKD IN PRIMARY CARE PRACTICE
    Litvin, Cara
    Ornstein, Steven M.
    Wessell, Andrea
    Nemeth, Lynne
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S106 - S106
  • [43] Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology - Introduction
    Culleton, Bruce F.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (03): : S1 - S3
  • [44] Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults
    Lougheed, M. Diane
    Lemiere, Catherine
    Ducharme, Francine M.
    Licskai, Chris
    Dell, Sharon D.
    Rowe, Brian H.
    FitzGerald, Mark
    Leigh, Richard
    Watson, Wade
    Boulet, Louis-Philippe
    CANADIAN RESPIRATORY JOURNAL, 2012, 19 (02) : 127 - 164
  • [45] KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease Foreword
    Kasiske, Bertram L.
    Wheeler, David C.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2013, 3 (03) : 260 - 260
  • [46] KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE
    de Boer, Ian H.
    Rossing, Peter
    Caramori, M. Luiza
    Chan, Juliana C. N.
    Heerspink, Hiddo J. L.
    Hurst, Clint
    Khunti, Kamlesh
    Liew, Adrian
    Michos, Erin D.
    Navaneethan, Sankar D.
    Olowu, Wasiu A.
    Sadusky, Tami
    Tandon, Nikhil
    Tuttle, Katherine R.
    Wanner, Christoph
    Wilkens, Katy G.
    Zoungas, Sophia
    Jadoul, Michel
    Winkelmayer, Wolfgang C.
    Tonelli, Marcello A.
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    Tunnicliffe, David J.
    Higgins, Gail Y.
    Natale, Patrizia
    Cooper, Tess E.
    Willis, Narelle S.
    KIDNEY INTERNATIONAL, 2022, 102 (05) : S1 - S127
  • [47] KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE EVALUATION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE
    Stevens, Paul E.
    Ahmed, Sofia B.
    Carrero, Juan Jesus
    Foster, Bethany
    Francis, Anna
    Hall, Rasheeda K.
    Herrington, Will G.
    Hill, Guy
    Inker, Lesley A.
    Kazancio, Rumeyza
    Lamb, Edmund
    Lin, Peter
    Levin, Adeera
    KIDNEY INTERNATIONAL, 2024, 105 (04) : S117 - S117
  • [48] Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis
    Rovin, Brad H.
    Ayoub, Isabelle M.
    Chan, Tak Mao
    Liu, Zhi-Hong
    Mejia-Vilet, Juan M.
    Balk, Ethan M.
    Gordon, Craig E.
    Adam, Gaelen
    Tonelli, Marcello A.
    Cheung, Michael
    Earley, Amy
    Floege, Jurgen
    KIDNEY INTERNATIONAL, 2024, 105 (01) : 31 - 34
  • [49] KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Foreword
    Kasiske, Bertram L.
    Wheeler, David C.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2013, 3 (01) : 2 - 2